A RANDOMIZED CONTROLLED TRIAL WITH THE α2-SUBUNIT PREFERRING GABA POSITIVE ALLOSTERIC MODULATOR, N-DESMETHYL-CLOBAZAM (NDMC) IN HEALTHY VOLUNTEERS